Safety and Efficacy of Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels in Pancreatic Surgery.

Katherine Kramme,Paya Sarraf,Saad Shebrain,Gitonga Munene

The American surgeon（2023）

引用 3|浏览4

暂无评分

摘要

Enoxaparin 40 mg once daily is associated with subprophylactic peak anti-Xa levels. Dose adjustment based on anti-Xa levels trended toward a lower rate of in-hospital VTE without an increase in bleeding or transfusion requirement.

查看译文

关键词

pancreas,surgical quality

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要